Algert Global’s Wave Life Sciences WVE Stock Holding History

Algert Global’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4M	Buy	2,817,615 +1,502,026	+114%	+$9.96M	0.19%	135
2026 Q1	$9.54M	Buy	1,315,589 +1,193,119	+974%	+$15.5M	0.14%	216
2025 Q4	$2.08M	Buy	+122,470	New	+$1.24M	0.03%	705
2025 Q3	–	Sell	-26,420	Closed	-$172K	–	1370
2025 Q2	$172K	Buy	+26,420	New	+$174K	﹤0.01%	1104
2025 Q1	–	Sell	-42,564	Closed	-$527K	–	1344
2024 Q4	$527K	Buy	+42,564	New	+$568K	0.01%	897
2022 Q2	–	Sell	-27,740	Closed	-$55K	–	1411
2022 Q1	$55K	Buy	27,740 +2,370	+9%	+$5.8K	﹤0.01%	1137
2021 Q4	$80K	Buy	+25,370	New	+$105K	0.01%	927

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Algert Global's WVE Position: Q2 2026 in Review

Algert Global increased its Wave Life Sciences (WVE) stake by 114% in Q2 2026, buying an estimated $9.96M and bringing the position to 2,817,615 shares worth $16.4M. The position accounts for 0.19% of the portfolio, ranked #135.

Algert Global first reported a position in WVE in Q4 2021 and has held it in 7 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Algert Global held 2,817,615 shares of Wave Life Sciences worth $16.4M as of Q2 2026.
Algert Global bought 1,502,026 Wave Life Sciences shares in Q2 2026, an estimated $9.96M.
Wave Life Sciences made up 0.19% of Algert Global's portfolio in Q2 2026, its #135 holding.
Algert Global first reported a position in Wave Life Sciences in Q4 2021 and has held it in 7 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.